Featured News Image Research news | Jun 24 2026 Knight Initiative for Brain Resilience Why do some cells die in ALS but not others? New Knight Initiative research identifies a molecular signature in vulnerable cells that could lead to treatments to promote ALS resilience Image Research news | Jun 17 2026 Wu Tsai Neurosciences Institute It’s time to revamp the motor homunculus An update to the 89-year-old model shows that the brain’s motor cortex isn’t as neatly organized as previously thought Image Research news | Jun 15 2026 Stanford Medicine Cell types' biological age predicts our disease risk A blood-test analysis can determine the biological ages of individual cell types and predict the health consequences Image Knight Initiative news | May 26 2026 Knight Initiative for Brain Resilience Slowing aging, predicting lifespan, and excitement for the future at the Knight ... The symposium showcased research ranging from rejuvenating the brain’s immune system to predicting cognitive health, and celebrated the next chapter of the Knight Initiative Displaying 1 - 3 news posts of 3 Filter Sort by Newest to oldest Oldest to newest News Type Wu Tsai Neuro News Knight Initiative news Director's messages Research news Researcher profiles News Features Awards and honors Podcast episodes Press coverage Publications Research Theme NeuroHealth NeuroEngineering Image Podcast episodes | Mar 14 2024 Wu Tsai Neurosciences Institute Mind Traveler This week, I join my producer Michael Osborne on his podcast, Famous and Gravy, to discuss the late, great neuroscientist and author Oliver Sacks. Image Researcher profiles | Jul 12 2023 Wu Tsai Neurosciences Institute Q&A: Using software engineering to bring back speech in ALS Erin Kunz, third year PhD student in Electrical Engineering, started her career developing autonomous vehicles at General Motors (GM) — but now she uses her software engineering and machine learning skills in the Neural Prosthetics Translational Lab. Image Research news | Feb 23 2022 Wu Tsai Neurosciences Institute Researchers connect ALS hallmark to gene Wu Tsai Neuro researchers have linked a specific gene known to be associated with ALS with a characteristic of the disease, opening avenues for a targeted therapy.
Image Research news | Jun 24 2026 Knight Initiative for Brain Resilience Why do some cells die in ALS but not others? New Knight Initiative research identifies a molecular signature in vulnerable cells that could lead to treatments to promote ALS resilience
Image Research news | Jun 17 2026 Wu Tsai Neurosciences Institute It’s time to revamp the motor homunculus An update to the 89-year-old model shows that the brain’s motor cortex isn’t as neatly organized as previously thought
Image Research news | Jun 15 2026 Stanford Medicine Cell types' biological age predicts our disease risk A blood-test analysis can determine the biological ages of individual cell types and predict the health consequences
Image Knight Initiative news | May 26 2026 Knight Initiative for Brain Resilience Slowing aging, predicting lifespan, and excitement for the future at the Knight ... The symposium showcased research ranging from rejuvenating the brain’s immune system to predicting cognitive health, and celebrated the next chapter of the Knight Initiative
Image Podcast episodes | Mar 14 2024 Wu Tsai Neurosciences Institute Mind Traveler This week, I join my producer Michael Osborne on his podcast, Famous and Gravy, to discuss the late, great neuroscientist and author Oliver Sacks.
Image Researcher profiles | Jul 12 2023 Wu Tsai Neurosciences Institute Q&A: Using software engineering to bring back speech in ALS Erin Kunz, third year PhD student in Electrical Engineering, started her career developing autonomous vehicles at General Motors (GM) — but now she uses her software engineering and machine learning skills in the Neural Prosthetics Translational Lab.
Image Research news | Feb 23 2022 Wu Tsai Neurosciences Institute Researchers connect ALS hallmark to gene Wu Tsai Neuro researchers have linked a specific gene known to be associated with ALS with a characteristic of the disease, opening avenues for a targeted therapy.
